Leadership Overview
Aurobindo Pharma has 5 executives leading key functions including financial strategy, API manufacturing, information technology, IT management, and regional operations.
Focused on delivering high-quality generic medications globally, Aurobindo Pharma maintains a commitment to pharmaceutical excellence through rigorous manufacturing standards and a diverse therapeutic portfolio that improves patient access to essential treatments.
Focused on delivering high-quality generic medications globally, Aurobindo Pharma maintains a commitment to pharmaceutical excellence through rigorous manufacturing standards and a diverse therapeutic portfolio that improves patient access to essential treatments.
Leadership Roles at Aurobindo Pharma
Santhanam Subramanian - Chief Financial Officer
Santhanam Subramanian, the Chief Financial Officer at Aurobindo Pharma, directs all global fiscal planning and capital allocation strategies. Managing the financial health of a massive generic pharmaceutical manufacturer, the Chief Financial Officer oversees complex budgetary frameworks and investor relations. Subramanian ensures the company maintains robust liquidity to support the production of active pharmaceutical ingredients and diverse therapeutic product lines. By analyzing market trends across international pharmaceutical sectors, the Chief Financial Officer optimizes cost structures and drives long-term shareholder value. Santhanam Subramanian monitors fiscal compliance and risk management protocols to protect the organization against volatile market shifts. Through precise financial forecasting, the Chief Financial Officer enables the company to scale manufacturing capabilities effectively. This leadership role requires constant collaboration with the board to align capital investments with the overarching mission of providing affordable healthcare solutions to global markets.
Anil Jain - Chief Operating Officer API Division
Anil Jain, the Chief Operating Officer API Division at Aurobindo Pharma, architects the manufacturing strategy for active pharmaceutical ingredients. Overseeing large-scale production facilities, the Chief Operating Officer API Division ensures that all chemical synthesis processes meet stringent international quality standards. Jain drives operational efficiency by integrating advanced automation into the manufacturing workflows for antibiotics and anti-diabetics. The Chief Operating Officer API Division coordinates with supply chain teams to maintain a steady flow of raw materials across global distribution networks. By optimizing production cycles, Anil Jain reduces waste and increases output capacity for the company. This role demands constant oversight of safety protocols and regulatory adherence within the manufacturing plants. Through strategic resource management, the Chief Operating Officer API Division supports the company's goal of dominating the generic pharmaceutical market by providing high-purity ingredients for diverse therapeutic areas.
Arvind Chandak - President, Operations (China)
Arvind Chandak, the President, Operations (China) at Aurobindo Pharma, directs all business activities and market expansion efforts within the East Asian region. Overseeing the manufacturing and distribution footprint, the President, Operations (China) ensures that the company's generic pharmaceutical portfolio reaches key regional healthcare providers. Chandak architects strategic partnerships with local distributors to increase market penetration for antibiotics and systemic gastroenterologicals. By managing regional regulatory compliance, the President, Operations (China) navigates complex legal landscapes to maintain consistent product availability. Arvind Chandak drives operational growth by aligning regional production targets with the company's global manufacturing capacity. This leadership role involves constant coordination with headquarters to ensure that regional strategies support the overall corporate mission. Through effective market analysis and operational oversight, the President, Operations (China) secures a strong competitive position for the company in one of the world's most critical pharmaceutical markets.
Chitti Babu - Group Chief Information Officer
Chitti Babu, the Group Chief Information Officer at Aurobindo Pharma, directs the digital transformation and enterprise technology strategy. Managing the entire IT infrastructure, the Group Chief Information Officer secures data integrity across all global manufacturing sites and corporate offices. Babu architects scalable cloud solutions that support the company's complex pharmaceutical supply chain and research databases. By implementing advanced cybersecurity measures, the Group Chief Information Officer protects proprietary drug formulations and sensitive patient data. Chitti Babu collaborates with executive leadership to integrate data analytics into daily operations, enhancing decision-making speed and accuracy. This leadership role involves overseeing the deployment of enterprise resource planning systems to streamline global workflows. Through continuous technological innovation, the Group Chief Information Officer ensures that the company remains competitive in the fast-paced pharmaceutical industry while maintaining seamless connectivity between international research and production hubs.
Vijay Kondakkagari - Manager, Information Technology
Vijay Kondakkagari, the Manager, Information Technology at Aurobindo Pharma, executes the daily technical operations and system maintenance for the organization. Overseeing the local and regional network stability, the Manager, Information Technology ensures that all manufacturing software remains operational and efficient. Kondakkagari manages the hardware lifecycle and software updates for internal teams, facilitating smooth communication across departments. By troubleshooting critical system issues, the Manager, Information Technology prevents downtime in the production of generic pharmaceuticals. Vijay Kondakkagari coordinates with the broader IT leadership to implement security patches and infrastructure upgrades that align with corporate standards. This role focuses on the tactical execution of technology policies that support the company's manufacturing goals. Through diligent monitoring of server performance and user support, the Manager, Information Technology maintains the technical foundation necessary for the company to deliver essential medications to global healthcare providers.
Explore Leadership Teams in Manufacturing
Johnson & Johnson is a global healthcare company that develops pharmaceuticals and medical technologies. It provides innovative medicines, surgical products, and medical devices used in areas such as oncology, immunology, neuroscience, and cardiovascular care, serving healthcare providers and patients worldwide.
Company Leadership
JM
VK

Alexion is a global biopharmaceutical company focused on the discovery, development, and commercialization of medicines for severe and life-threatening rare disorders. The company was established in 1992 and is headquartered in Boston, Massachusetts.
Company Leadership AM
SG
YS
MH
Gufic Group is a respected player in the pharmaceutical industry, established in 1970, known for its innovative and high-quality pharmaceutical and herbal products, along with a diverse range of APIs. They are recognized as one of India's largest manufacturers of lyophilized injections, offering a variety of products including antibiotics, antifungals, and antiviral treatments. Their extensive network facilitates the supply of these products to major hospital chains and leading medical facilities across India. Gufic is committed to research and development, continuously launching advanced new products while expanding their international footprint.
Company Leadership SD

NY
EVA Pharma is a leading player in the Egyptian pharmaceutical industry, dedicated to innovating healthcare solutions that enhance the quality of life. With over 300 products in its portfolio and a robust pipeline of 500 products, the company focuses on addressing unmet medical needs across various therapeutic areas including oncology, neuroscience, and cardiometabolic medicine. EVA Pharma operates three internationally accredited manufacturing facilities and has a strong commitment to partnerships that facilitate access to life-saving treatments in low- to middle-income countries. With a century of expertise, the company emphasizes research and development as a core aspect of its operations.
Company Leadership
BM
EG
KN